{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Thanapirom K"],"funding":["Ratchadaphiseksomphot Endowment Fund of Center of Excellence in Hepatic Fibrosis and Cirrhosis, Chulalongkorn University","Liver Research Unit, and the Fatty Liver Unit, Division of Gastroenterology of the Faculty of Medicine, Chulalongkorn University"],"pagination":["5796"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10924893"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["14(1)"],"pubmed_abstract":["The relationship between ammonia and liver-related complications (LRCs) in acute-on-chronic liver failure (ACLF) patients is not clearly established. This study aimed to evaluate the association between ammonia levels and LRCs in patients with ACLF. The study also evaluated the ability of ammonia in predicting mortality and progression of LRCs. The study prospectively recruited ACLF patients based on the APASL definition from the ACLF Research Consortium (AARC) from 2009 to 2019. LRCs were a composite endpoint of bacterial infection, overt hepatic encephalopathy (HE), and ascites. A total of 3871 cases were screened. Of these, 701 ACLF patients were enrolled. Patients with LRCs had significantly higher ammonia levels than those without. Ammonia was significantly higher in patients with overt HE and ascites, but not in those with bacterial infection. Multivariate analysis found that ammonia was associated with LRCs. Additionally, baseline arterial ammonia was an independent predictor of 30-day mortality, but it was not associated with the development of new LRCs within 30 days. In summary, baseline arterial ammonia levels are associated with 30-day mortality and LRCs, mainly overt HE and ascites in ACLF patients."],"journal":["Scientific reports"],"pubmed_title":["Ammonia is associated with liver-related complications and predicts mortality in acute-on-chronic liver failure patients."],"pmcid":["PMC10924893"],"funding_grant_id":["GCE 3300170037"],"pubmed_authors":["Sood A","Arora A","Sahu M","Thanapirom K","Eapen CE","Shresta A","Kumar R","Prasad VGM","Hamid SS","Al Mahtab M","Sollano J","Dhiman RK","Choudhury A","Kim DJ","Dokmeci AK","Treeprasertsuk S","Shukla A","Tao H","Verma N","Sarin SK","Devarbhavi H","Payawal DA","Ghazinyan H","Jafri W","Lee GH","Yuemin N","Lau G","Kumar A","Tan SS"],"additional_accession":[]},"is_claimable":false,"name":"Ammonia is associated with liver-related complications and predicts mortality in acute-on-chronic liver failure patients.","description":"The relationship between ammonia and liver-related complications (LRCs) in acute-on-chronic liver failure (ACLF) patients is not clearly established. This study aimed to evaluate the association between ammonia levels and LRCs in patients with ACLF. The study also evaluated the ability of ammonia in predicting mortality and progression of LRCs. The study prospectively recruited ACLF patients based on the APASL definition from the ACLF Research Consortium (AARC) from 2009 to 2019. LRCs were a composite endpoint of bacterial infection, overt hepatic encephalopathy (HE), and ascites. A total of 3871 cases were screened. Of these, 701 ACLF patients were enrolled. Patients with LRCs had significantly higher ammonia levels than those without. Ammonia was significantly higher in patients with overt HE and ascites, but not in those with bacterial infection. Multivariate analysis found that ammonia was associated with LRCs. Additionally, baseline arterial ammonia was an independent predictor of 30-day mortality, but it was not associated with the development of new LRCs within 30 days. In summary, baseline arterial ammonia levels are associated with 30-day mortality and LRCs, mainly overt HE and ascites in ACLF patients.","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Mar","modification":"2025-04-04T12:58:49.335Z","creation":"2025-04-04T12:58:49.335Z"},"accession":"S-EPMC10924893","cross_references":{"pubmed":["38461166"],"doi":["10.1038/s41598-024-56401-x"]}}